サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1446478

細胞シグナル伝達市場の市場規模、シェア、動向分析レポート：タイプ別、製品別、技術別、経路別、地域別、セグメント別予測、2024年～2030年

Cell Signaling Market Size, Share & Trends Analysis Report By Type (Endocrine Signaling, Paracrine Signaling), By Product, By Technology, By Pathway, By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 110 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
細胞シグナル伝達市場の市場規模、シェア、動向分析レポート：タイプ別、製品別、技術別、経路別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年02月05日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞シグナル伝達市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の細胞シグナル伝達市場規模は2030年までに89億4,000万米ドルに達すると予測されています。

2024年から2030年までのCAGRは7.56％と推定されます。幹細胞研究が重視されるようになったことが、細胞シグナル伝達業界の成長と開発に大きく寄与しています。幹細胞は、細胞の分化と発生の複雑なプロセスを研究するモデルシステムを提供します。細胞シグナル伝達経路は、幹細胞を特定の細胞分化に向かわせる上で重要な役割を果たしており、細胞シグナル伝達技術は市場全体の拡大に大きく貢献する信頼できるツールとなっています。

さらに、幹細胞は創薬や疾患モデリングにおいても極めて重要な役割を担っており、細胞シグナル伝達研究は、治療化合物によって調節される経路や、様々な疾患で観察される調節異常に関する重要な知識を提供しています。政府からの資金援助が増加していることも、幹細胞研究の発展を後押ししています。例えば、2020年3月、カナダ政府は再生医療と幹細胞研究のために約700万米ドルを割り当て、9つの国際プロジェクトと4つの国内臨床試験を支援することを目的としており、再生医療分野の拡大に貢献しています。したがって、幹細胞の需要が高まるにつれて、細胞シグナル伝達プロセスの市場成長も促進されます。

さらに、オミックス技術の台頭などの技術的進歩は、市場成長を促進する上で重要な役割を果たしています。オミックス技術は、特定の細胞シグナル伝達イベントに関連するバイオマーカーの同定を容易にします。これらのバイオマーカーは、疾患の早期発見、予後予測、治療反応のモニタリングにおいて重要な役割を果たす、正常な細胞機能または疾患に関連する異常の指標となります。このように、これらの技術の応用は細胞シグナル伝達経路の理解を深め、細胞シグナル伝達産業の成長に大きく貢献しています。

細胞シグナル伝達市場レポートハイライト

  • タイプ別では、内分泌シグナル伝達が市場を独占し、2023年の収益シェアは42.9%でした。副腎不全、クッシング病、巨大症、甲状腺機能低下症、甲状腺機能亢進症などの内分泌関連疾患の有病率の増加は、市場拡大を促進する主な要因の1つです。
  • 製品別では、消耗品が2023年に58.3%の最大収益シェアを占めました。これは、試薬、検査キット、抗体を含む製品別の結果、細胞シグナル伝達の必要性が高まっていることに起因しています。医療用品産業の拡大も、同分野の需要を押し上げる要因のひとつです。
  • 技術別では、顕微鏡検査が2023年の売上高シェア35.8%で市場を独占しています。近年の技術躍進につながる要因として、光学顕微鏡の開発が加速しており、このセグメントの需要を押し上げています。
  • 経路別では、AKTシグナル伝達経路セグメントが2023年に43.1%と圧倒的なシェアを占めています。AKT経路のダウンレギュレーションに基づく商業的診断検査の開発が予測され、予測期間中、細胞シグナル伝達分野が繁栄する原動力となります。
  • 北米は、2023年に40.3%の収益シェアで世界の業界を支配しましたが、これはこの地域に主要な市場企業が存在するためです。この地域の細胞シグナル伝達産業の主要企業の大半は、細胞シグナル伝達経路に関わる研究開発活動に積極的に関与しています。

目次

第1章 調査手法と範囲

第2章 細胞シグナル伝達市場：エグゼクティブサマリー

  • 市場の見通し
  • セグメントのスナップショット
  • 競合情勢のスナップショット

第3章 細胞シグナル伝達市場の変数、動向、および範囲

  • 市場セグメンテーションと範囲
  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
  • 市場促進要因分析
    • 慢性疾患の発生率の増加
    • 細胞シグナル伝達調査における技術の進歩
  • 市場抑制要因分析
    • 細胞シグナル伝達調査に関連する高額なコスト
  • 事業環境分析
    • ポーターのファイブフォース分析
    • PESTLE分析
    • COVID-19の分析

第4章 細胞シグナル伝達市場：タイプの推定・動向分析

  • 細胞シグナル伝達市場：タイプ変動分析
  • 内分泌シグナル伝達
  • パラクリンシグナル伝達
  • 自己分泌シグナル伝達
  • その他

第5章 細胞シグナル伝達市場：製品推定・動向分析

  • 細胞シグナル伝達市場：製品変動分析
  • 消耗品
  • 器具

第6章 細胞シグナル伝達市場：技術推定・動向分析

  • 細胞シグナル伝達市場：技術変動分析
  • フローサイトメトリー
  • 顕微鏡検査
  • ウェスタンブロッティング
  • ELISA
  • その他

第7章 細胞シグナル伝達市場：経路推定・動向分析

  • 細胞シグナル伝達市場：パスウェイ変動分析
  • AKTシグナル伝達経路
  • AMPKシグナル伝達経路
  • ErbB/HERシグナル伝達経路
  • 他のシグナル伝達経路

第8章 細胞シグナル伝達市場：地域ビジネス分析

  • 地域市場のスナップショット
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合情勢

  • 企業の分類
  • 戦略マッピング
    • 買収
    • 製品/サービスの発売
    • パートナーシップ/コラボレーション
    • その他
  • 市況分析、2023年
  • 企業プロファイル
    • Thermo Fisher Scientific, Inc.
    • QIAGEN
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories Inc.
    • Bio-Techne Corporation
    • Cell Signaling Technology Inc.
    • Danaher
    • Merck KGaA
    • PerkinElmer Inc.
    • Promega Corporation
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 6 Global Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 7 Global Cell Signaling Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Cell Signaling Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 North America Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 North America Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 North America Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 13 U.S. Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 15 U.S. Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 17 Canada Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 19 Canada Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 20 Canada Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 21 Europe Cell Signaling Market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 24 Europe Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 Europe Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 26 UK Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 UK Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 28 UK Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 29 UK Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 30 Germany Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 Germany Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Germany Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 33 Germany Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 34 France Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 France Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 France Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 France Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 38 Italy Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 40 Italy Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Italy Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 42 Spain Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Spain Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 44 Spain Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 45 Spain Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 46 Sweden Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Sweden Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 Sweden Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 49 Sweden Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 50 Norway Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Norway Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Norway Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 Norway Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 54 Denmark Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Denmark Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 56 Denmark Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Denmark Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Cell Signaling Market, by Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 63 Japan Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 64 Japan Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 65 Japan Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 Japan Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 67 China Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 China Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 69 China Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 70 China Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 71 India Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 India Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 India Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 74 India Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 75 Australia Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 76 Australia Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 Australia Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 78 Australia Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 79 South Korea Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 80 South Korea Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 81 South Korea Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 82 South Korea Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 83 Thailand Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 84 Thailand Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 85 Thailand Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 86 Thailand Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 87 Latin America Cell Signaling Market, by Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 89 Latin America Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 90 Latin America Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 91 Latin America Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 92 Brazil Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 93 Brazil Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 94 Brazil Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Brazil Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 96 Mexico Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 97 Mexico Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 98 Mexico Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 99 Mexico Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 100 Argentina Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 101 Argentina Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 102 Argentina Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 103 Argentina Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 104 MEA Cell Signaling Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 MEA Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 106 MEA Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 107 MEA Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 108 MEA Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 109 South Africa Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 110 South Africa Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 111 South Africa Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 112 South Africa Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 117 UAE Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 118 UAE Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 119 UAE Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 120 UAE Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Cell Signaling Market, by Type, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Cell Signaling Market, by Product, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Cell Signaling Market, by Technology, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Cell Signaling Market, by Pathway, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Cell Signaling Market Segmentation
  • Fig. 8 Market Snapshot, 2023
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration & Growth Prospect Mapping, 2023
  • Fig. 15 Global Cell Signaling Market: Type Movement Analysis
  • Fig. 16 Global Cell Signaling Market, For Endocrine Signaling, 2018 - 2030 (USD Million)
  • Fig. 17 Global Cell Signaling Market, For Paracrine Signaling, 2018 - 2030 (USD Million)
  • Fig. 18 Global Cell Signaling Market, For Autocrine Signaling, 2018 - 2030 (USD Million)
  • Fig. 19 Global Cell Signaling Market, For Others, 2018 - 2030 (USD Million)
  • Fig. 20 Global Cell Signaling Market: Product Movement Analysis
  • Fig. 21 Global Cell Signaling Market, For Consumables, 2018 - 2030 (USD Million)
  • Fig. 22 Global Cell Signaling Market, For Instruments, 2018 - 2030 (USD Million)
  • Fig. 23 Global Cell Signaling Market: Technology Movement Analysis
  • Fig. 24 Global Cell Signaling Market, For Flow Cytometry, 2018 - 2030 (USD Million)
  • Fig. 25 Global Cell Signaling Market, For Microscopy, 2018 - 2030 (USD Million)
  • Fig. 26 Global Cell Signaling Market, For Western Blotting, 2018 - 2030 (USD Million)
  • Fig. 27 Global Cell Signaling Market, For ELISA, 2018 - 2030 (USD Million)
  • Fig. 28 Global Cell Signaling Market, For Others, 2018 - 2030 (USD Million)
  • Fig. 29 Global Cell Signaling Market: Pathway Movement Analysis
  • Fig. 30 Global Cell Signaling Market, For AKT Signaling Pathway, 2018 - 2030 (USD Million)
  • Fig. 31 Global Cell Signaling Market, For AMPK Signaling Pathway, 2018 - 2030 (USD Million)
  • Fig. 32 Global Cell Signaling Market, For Erbb/HER Signaling Pathway, 2018 - 2030 (USD Million)
  • Fig. 33 Global Cell Signaling Market, For Other Signaling Pathways, 2018 - 2030 (USD Million)
  • Fig. 34 Regional Marketplace: Key Takeaways
  • Fig. 35 Regional Outlook, 2023 & 2030
  • Fig. 36 Global Cell Signaling Market: Regional Movement Analysis
  • Fig. 37 North America Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 42 UK Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 43 France Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 50 Japan Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 51 China Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 52 India Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 53 Australia Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 56 Latin America Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 57 Brazil Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 58 Mexico Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 59 Argentina Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 60 Middle East & Africa Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 63 UAE Cell Signaling Market, 2018 - 2030 (USD Million)
  • Fig. 64 Kuwait Cell Signaling Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-190-8

Cell Signaling Market Growth & Trends:

The global cell signaling market size is expected to reach USD 8.94 billion by 2030, according to a new report by Grand View Research, Inc. The market is estimated to register a CAGR of 7.56% from 2024 to 2030. A rising emphasis on stem cell research significantly contributes to the growth and development of the cell signaling industry. Stem cells provide a model system to study the intricate processes of cellular differentiation and development. Cell signaling pathways play a crucial role in directing stem cells toward specific cell differentiation, rendering cell signaling technology a dependable tool that significantly contributes to overall market expansion.

Furthermore, stem cells also play a pivotal role in drug discovery and disease modeling, with cell signaling research providing essential knowledge on the pathways modulated by therapeutic compounds and the dysregulations observed in various diseases. Rising government funding further boosts developments in stem cell research. For instance, in March 2020, Canada's government allocated approximately USD 7 million towards regenerative medicine and stem cell research with an aim to support nine transnational projects and four clinical trials within the country, contributing to the expansion of the regenerative medicine sector. Therefore, as the demand for stem cells rises, it consequently propels market growth for cell signaling process.

Additionally, technological advancements such as rising omics technologies play a significant role in driving market growth. Omics technologies facilitate the identification of biomarkers associated with specific cell signaling events.These biomarkers serve as indicators of normal cellular function or aberrations linked to diseases, which plays a crucial role in early disease detection, prognosis, and monitoring treatment responses. Thus, the application of these technologies enhances the understanding of cell signaling pathways and contributes significantly to the growth of the cell signaling industry.

Cell Signaling Market Report Highlights:

  • Based on type, endocrine signaling dominated the market with a revenue share of 42.9% in 2023. The increased prevalence of endocrine-related disorders such as adrenal insufficiency, Cushing's disease, gigantism, hypothyroidism, as well as hyperthyroidism is one of the primary drivers driving market expansion
  • In terms of product, consumables held the largest revenue share of 58.3% in 2023. This has been ascribed to the increasing need for cell signaling as a result of byproducts that include reagents, test kits, and antibodies. Expansion of the medical supplies industry is another factor driving segment demand
  • On the basis of technology, microscopy dominates the market with a revenue share of 35.8% in 2023. The factors that can be linked to technological breakthroughs in recent years have accelerated the development of light microscopy, which is boosting demand for this segment
  • Based on pathway, the AKT signaling pathway segment held a dominant share of 43.1% in 2023. The predicted development of commercial diagnostic tests based on AKT pathway downregulation will drive the cell signaling sector to flourish over the forecast timeframe
  • North America dominated the global industry in 2023 with a revenue share of 40.3%, owing to the presence of key market players in this region. Majority of the key companies in this region's cell signaling industry have been actively involved in R&D activities involving cell signaling pathways

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
  • 1.2. Information analysis
  • 1.3. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Cell Signaling Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Cell Signaling Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising incidence of chronic diseases
    • 3.4.2. Technological advancement in cell based signaling research
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost associated with cell signaling research
  • 3.6. Business Environment Analysis
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTLE Analysis
    • 3.6.3. COVID-19 Analysis

Chapter 4. Cell Signaling Market: Type Estimates & Trend Analysis

  • 4.1. Cell Signaling Market: Type Movement Analysis
  • 4.2. Endocrine Signaling
    • 4.2.1. Endocrine Signaling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3. Paracrine Signaling
    • 4.3.1. Paracrine Signaling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Autocrine Signaling
    • 4.4.1. Autocrine Signaling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Cell Signaling Market: Product Estimates & Trend Analysis

  • 5.1. Cell Signaling Market: Product Movement Analysis
  • 5.2. Consumables
    • 5.2.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3. Instruments
    • 5.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Cell Signaling Market: Technology Estimates & Trend Analysis

  • 6.1. Cell Signaling Market: Technology Movement Analysis
  • 6.2. Flow Cytometry
    • 6.2.1. Flow Cytometry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Microscopy
    • 6.3.1. Microscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Western Blotting
    • 6.4.1. Western Blotting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. ELISA
    • 6.5.1. ELISA Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Cell Signaling Market: Pathway Estimates & Trend Analysis

  • 7.1. Cell Signaling Market: Pathway Movement Analysis
  • 7.2. AKT Signaling Pathway
    • 7.2.1. AKT Signaling Pathway Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. AMPK Signaling Pathway
    • 7.3.1. AMPK Signaling Pathway Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. ErbB/HER Signaling Pathway
    • 7.4.1. ErbB/HER Signaling Pathway Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Other Signaling Pathways
    • 7.5.1. Other Signaling Pathways Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Cell Signaling Market: Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Cell Signaling Market 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Competitive Scenario
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Target Disease Prevalence
      • 8.2.2.5. U.S. Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.2.3. CANADA
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Competitive Scenario
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Target Disease Prevalence
      • 8.2.3.5. Canada Cell Signaling Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Target Disease Prevalence
      • 8.3.2.5. UK Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.3.3. GERMANY
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Target Disease Prevalence
      • 8.3.3.5. Germany Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.3.4. SPAIN
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Target Disease Prevalence
      • 8.3.4.5. Spain Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.3.5. FRANCE
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Competitive Scenario
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Target Disease Prevalence
      • 8.3.5.5. France Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.3.6. ITALY
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Competitive Scenario
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Target Disease Prevalence
      • 8.3.6.5. Italy Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.3.7. DENMARK
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Competitive Scenario
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Target Disease Prevalence
      • 8.3.7.5. Denmark Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.3.8. SWEDEN
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Competitive Scenario
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Target Disease Prevalence
      • 8.3.8.5. Sweden Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.3.9. NORWAY
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Competitive Scenario
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Target Disease Prevalence
      • 8.3.9.5. Norway Cell Signaling Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia-Pacific Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.4.2. JAPAN
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Target Disease Prevalence
      • 8.4.2.5. Japan Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.4.3. CHINA
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Target Disease Prevalence
      • 8.4.3.5. China Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.4.4. INDIA
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Target Disease Prevalence
      • 8.4.4.5. India Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.4.5. SOUTH KOREA
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Target Disease Prevalence
      • 8.4.5.5. South Korea Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.4.6. THAILAND
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Target Disease Prevalence
      • 8.4.6.5. Thailand Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.4.7. AUSTRALIA
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Target Disease Prevalence
      • 8.4.7.5. Australia Cell Signaling Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.5.2. BRAZIL
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Target Disease Prevalence
      • 8.5.2.5. Brazil Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.5.3. MEXICO
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Target Disease Prevalence
      • 8.5.3.5. Mexico Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.5.4. ARGENTINA
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Target Disease Prevalence
      • 8.5.4.5. Argentina Cell Signaling Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.6.2. SOUTH AFRICA
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Target Disease Prevalence
      • 8.6.2.5. South Africa Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.6.3. SAUDI ARABIA
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Target Disease Prevalence
      • 8.6.3.5. Saudi Arabia Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Target Disease Prevalence
      • 8.6.4.5. UAE Cell Signaling Market, 2018 - 2030 (USD Million)
    • 8.6.5. KUWAIT
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Target Disease Prevalence
      • 8.6.5.5. Kuwait Cell Signaling Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. Acquisitions
    • 9.2.2. Product/Service Launches
    • 9.2.3. Partnerships/Collaborations
    • 9.2.4. Others
  • 9.3. Market Position Analysis, 2023
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. QIAGEN
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Becton, Dickinson and Company
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Bio-Rad Laboratories Inc.
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Bio-Techne Corporation
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Cell Signaling Technology Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Benchmarking
      • 9.4.6.3. Strategic Initiatives
    • 9.4.7. Danaher
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Merck KGaA
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. PerkinElmer Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Promega Corporation
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives